Bactrim and Jublia drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bactrim (sulfamethoxazole; trimethoprim) and Jublia (efinaconazole). Common drug interactions include adverse drug reaction among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Bactrim and Jublia. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Bactrim?

Bactrim has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 89,117 Bactrim users. Check the latest studies of Bactrim.

What is Jublia?

Jublia has active ingredients of efinaconazole. eHealthMe is studying from 1,780 Jublia users. Check the latest studies of Jublia.



On Jul, 15, 2026

14 people who take Bactrim and Jublia together, and have interactions are studied.

Bactrim and Jublia drug interactions.

What are the common drug interactions of Bactrim and Jublia, by gender? *:

female:

  1. Adverse drug reaction
  2. Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
  3. Aphasia (damage to the parts of the brain that control language)
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Blood pressure increased
  7. Blood sodium increased
  8. Colonoscopy
  9. Confusional state
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Dry mouth
  4. Fatigue (feeling of tiredness)
  5. Feeling hot
  6. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
  7. Hip arthroplasty
  8. Hyperkalaemia (damage to or disease of the kidney)
  9. Ileus (a painful obstruction of the ileum or other part of the intestine)
  10. Leukopenia (less number of white blood cells in blood)

What are the common drug interactions of Bactrim and Jublia, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Asthenia (weakness)
  2. Blood bilirubin increased
  3. Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
  4. Headache (pain in head)
  5. Malaise (a feeling of general discomfort or uneasiness)
  6. Nausea (feeling of having an urge to vomit)
  7. Upper respiratory tract infection
  8. Vomiting

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Emotional distress
  5. Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
  6. Hypertension (high blood pressure)
  7. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  8. Nephrotic syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema)
  9. Pain
  10. Renal failure (kidney dysfunction)

60+:

  1. Diarrhoea
  2. Weight decreased
  3. Confusional state
  4. Contusion (a type of hematoma of tissue in which capillaries)
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Dizziness
  7. Dry eye (lack of adequate tears)
  8. Fall
  9. Fungal skin infection
  10. Haemorrhage (bleeding)

What are the existing conditions these people have? *

  1. Hiv Infection: 3 people, 21.43%
  2. Pain: 3 people, 21.43%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 21.43%
  4. Renal Cell Carcinoma (a kidney cancer): 2 people, 14.29%
  5. Psoriasis (immune-mediated disease that affects the skin): 2 people, 14.29%
  6. Peripheral Swelling: 2 people, 14.29%
  7. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 14.29%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 2 people, 14.29%
  9. Multiple Myeloma (cancer of the plasma cells): 2 people, 14.29%
  10. Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Bactrim and Jublia?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bactrim and Jublia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bactrim:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Jublia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bactrim and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Jublia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on sulfamethoxazole; trimethoprim and efinaconazole (the active ingredients of Bactrim and Jublia, respectively), and Bactrim and Jublia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: